作者报告３０例小骨窗开颅及基因重组链激酶（ｒ－ＳＫ）局部应用治疗高血压脑出血的方法和结果。局部应用ｒ－ＳＫ排出血肿量６～２６ｍｌ，平均１３．５ｍｌ，无１例发生再出血和过敏反应，手术死亡率１３．３％。认为小骨窗开颅加ｒ－ＳＫ局部应用溶化引流血肿治疗高血压脑出血是值得推广的新方法。 The authors report the methods and results of 30 patients with hypertensive intracerebral hemorrhage (ICH) treated by craniotomy and gene recombinant streptokinase (r-SK). Topical application of r-SK hematoma volume was 6 ~ 26ml, an average of 13.5ml, no one case of rebleeding and allergic reactions, the operative mortality rate of 13.3%. That small bone window craniotomy plus r-SK local application of melted drainage hematoma hypertensive cerebral hemorrhage is worth promoting a new method.